Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
BG9418 (interferon beta-1a)
DRUG
3 trials
Sponsors
Biogen
Conditions
Active Ulcerative Colitis
Multiple Sclerosis
Pregnancy
Prenatal Exposure Delayed Effects
Phase 2
A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis
Completed
NCT00616434
Biogen
Active Ulcerative Colitis
Start: 2008-05-31
End: 2010-03-31
Updated: 2014-08-13
Phase 3
Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects
Completed
NCT00828204
Biogen
Multiple Sclerosis
Start: 2009-01-31
End: 2010-10-31
Updated: 2014-06-03
Unknown Phase
Pregnancy Exposure Registry for Avonex (Interferon Beta-1a)
Completed
NCT00168714
Biogen
Multiple Sclerosis, Pregnancy, Prenatal Exposure Delayed Effects
Start: 2004-02-29
End: 2011-09-30
Updated: 2014-06-09
Related Papers
Analysis of Pregnancy Outcomes Following Exposure to Intramuscular Interferon Beta-1a: The AVONEX<sup>®</sup> Pregnancy Exposure Registry.
2023-09-22
1 citations
An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjects.
2011-10-14
32 citations